EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Association between multioil intravenous lipid emulsion and cholestasis in infants with gastrointestinal disorders: A retrospective cohort study

Lauren J Lee, Esther S Kim, Tahmineh Romero, Kara L Calkins iD

Journal of Parenteral and Enteral Nutrition · 2025

DOI: 10.1002/jpen.2776 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Parenteral and Enteral Nutrition, 2025. Verfasst von Lauren J Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Fat Emulsions, Intravenous, Cholestasis, Parenteral Nutrition, Gastrointestinal Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS, David Geffen School of Medicine, University of California, Los Angeles, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Infants with gastrointestinal (GI) disorders are at risk for parenteral nutrition–associated cholestasis. A multioil intravenous lipid emulsion (MO ILE) contains less phytosterols and more arachidonic and docosahexaenoic acid (DHA) than 100% soybean oil lipid emulsion (SO ILE). This study compares parenteral nutrition–associated cholestasis, growth, and fatty acids in infants with GI disorders who received MO ILE or SO ILE.

Methods

This retrospective cohort study included 48 infants with GI disorders born between 2014 and 2022 who received an intravenous lipid emulsion for ≥14 days. Cholestasis was defined as serum conjugated bilirubin ≥ 2 mg/dl; growth was assessed by z score changes. Gas chromatography and mass spectrometry was used to measure fatty acid content in the erythrocyte cell membrane.

Results

The incidence of parenteral nutrition–associated cholestasis was similar (MO ILE 30% vs SO ILE 29%, P > 0.99). However, compared with infants who received parenteral nutrition >28 days and SO ILE, infants who received parenteral nutrition >28 days and MO ILE experienced a slower rise in conjugated bilirubin (0.1 ± 0.03 vs 0.26 ± 0.38 mg/dl, P interaction < 0.001). Weight z score decline (discharge to birth) was less in the MO ILE group vs SO ILE group (−1.0 [−2.0, −0.4] vs −0.4 [−0.9, 0], P = 0.04). Although the MO ILE group demonstrated improved DHA status at weeks 1–3 ( P < 0.05 for all), arachidonic acid and DHA decreased over time in both groups and there was no difference in the rate of change ( P interaction > 0.3 for both).

Conclusion

In infants with GI disorders, MO ILE was associated with improved growth. MO ILE was well tolerated and hepatoprotective in infants who required prolonged parenteral nutrition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fat Emulsions, IntravenousCholestasisParenteral NutritionGastrointestinal DiseasesHumansRetrospective StudiesMaleFemaleSoybean OilInfantInfant, NewbornBilirubinDocosahexaenoic AcidsArachidonic AcidPhytosterolsFatty Acids

Stichwörter der Autor:innen

gastroenterologylife cyclelipidsneonatesnutritionparenteral nutritionresearch and diseasesshort bowel syndrome

Substanzen

Fat Emulsions, IntravenousSoybean OilBilirubinDocosahexaenoic AcidsArachidonic AcidPhytosterolsFatty Acids

Autor:innen und Institutionen

  • David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
  • Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Department of Pediatrics, Division of Neonatology and Developmental Biology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
  • Department of Medicine, Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.

ORCID-Profile: Kara L Calkins

Förderung

  • NCATS NIH HHS
  • David Geffen School of Medicine, University of California, Los Angeles
  • NIH HHS

Zitieren

APA

Lee, L. J., Kim, E. S., Romero, T., & Calkins, K. L. (2025). Association between multioil intravenous lipid emulsion and cholestasis in infants with gastrointestinal disorders: A retrospective cohort study. Journal of Parenteral and Enteral Nutrition. https://doi.org/10.1002/jpen.2776

Vancouver

Lee LJ, Kim ES, Romero T, Calkins KL. Association between multioil intravenous lipid emulsion and cholestasis in infants with gastrointestinal disorders: A retrospective cohort study. Journal of Parenteral and Enteral Nutrition. 2025. doi:10.1002/jpen.2776

BibTeX
@article{Lee2025,
  author = {Lee, Lauren J and Kim, Esther S and Romero, Tahmineh and Calkins, Kara L},
  title = {Association between multioil intravenous lipid emulsion and cholestasis in infants with gastrointestinal disorders: A retrospective cohort study},
  journal = {Journal of Parenteral and Enteral Nutrition},
  year = {2025},
  doi = {10.1002/jpen.2776}
}
Kostenlos starten →